Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00186628
Status:
COMPLETED
Last Update Posted:
2017-11-28
First Post:
2005-09-14
Brief Title:
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Sponsor:
Organization:
Stanford University